GlycoMimetics, Inc. (GLYC): Price and Financial Metrics

GlycoMimetics, Inc. (GLYC): $0.33

0.05 (-12.95%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

Add GLYC to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#234 of 358

in industry

GLYC Price/Volume Stats

Current price $0.33 52-week high $3.53
Prev. close $0.38 52-week low $0.14
Day low $0.31 Volume 3,481,600
Day high $0.37 Avg. volume 7,124,436
50-day MA $0.24 Dividend yield N/A
200-day MA $0.97 Market Cap 21.28M

GLYC Stock Price Chart Interactive Chart >


GlycoMimetics, Inc. (GLYC) Company Bio


GlycoMimetics, Inc., a clinical stage biotechnology company, focuses on the discovery and development of glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. The company is developing its lead product candidates include rivipansel, a pan-selectin antagonist, which is in Phase III clinical trials for the treatment of vaso-occlusive crisis, a debilitating and painful condition that occurs periodically throughout the life of a person with sickle cell disease; and GMI-1271, an E-selectin antagonist to treat acute myeloid leukemia and other hematologic cancers. The company was founded in 2003 and is based in Rockville, Maryland.


GLYC Latest News Stream


Event/Time News Detail
Loading, please wait...

GLYC Latest Social Stream


Loading social stream, please wait...

View Full GLYC Social Stream

GLYC Price Returns

1-mo 100.00%
3-mo 73.68%
6-mo 22.22%
1-year -78.29%
3-year -82.07%
5-year -93.32%
YTD -86.02%
2023 -22.11%
2022 110.42%
2021 -61.70%
2020 -28.92%
2019 -44.14%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!